BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1386752)

  • 1. A successful regimen for the prevention of seroconversion after transplantation of a heart positive for hepatitis B surface antigen.
    Turik MA; Markowitz SM
    J Heart Lung Transplant; 1992; 11(4 Pt 1):781-3. PubMed ID: 1386752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Persistent HBsAg antigenemia in newborn infants following intrauterine HBV infection. Cause for the failure of the prevention of perinatal HBV transmission].
    Pongpipat D; Suvatte V; Assateerawatts A
    Monatsschr Kinderheilkd; 1986 Jul; 134(7):473-4. PubMed ID: 2943988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of a mass hepatitis B vaccination program in Taiwan. Studies on 3464 infants of hepatitis B surface antigen-carrier mothers.
    Hsu HM; Chen DS; Chuang CH; Lu JC; Jwo DM; Lee CC; Lu HC; Cheng SH; Wang YF; Wang CY
    JAMA; 1988 Oct; 260(15):2231-5. PubMed ID: 2971827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined passive and active immunization for interruption of perinatal transmission of hepatitis B virus in Taiwan.
    Lo KJ; Tsai YT; Lee SD; Yeh CL; Wang JY; Chiang BN; Wu TC; Yeh PS; Goudeau A; Coursaget P
    Hepatogastroenterology; 1985 Apr; 32(2):65-8. PubMed ID: 3159639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combination of hepatitis B vaccine and immunoglobulin does not protect all infants born to hepatitis B e antigen positive mothers.
    Farmer K; Gunn T; Woodfield DG
    N Z Med J; 1987 Jul; 100(827):412-4. PubMed ID: 2967932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developments in immunization against hepatitis B.
    Zuckerman AJ
    Ann Ist Super Sanita; 1987; 24(2):285-91. PubMed ID: 2969206
    [No Abstract]   [Full Text] [Related]  

  • 7. [HBsAG-positive mothers and neonatal immunization: experience at the USL No. 1 in Trapani].
    Bonanno Conti MI; Critti AF; La Rocca S; Rappa AR
    Minerva Pediatr; 1990 Jun; 42(6):233-5. PubMed ID: 2147456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B immunization in high risk neonates born from HBsAg positive mothers: comparison between plasma derived and recombinant DNA vaccine.
    Pongpipat D; Suvatte V; Assateerawatts A
    Asian Pac J Allergy Immunol; 1989 Jun; 7(1):37-40. PubMed ID: 2526633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year study of passive-active immunization for prevention of hepatitis B infection in newborns.
    Theppisai U; Thanuntaseh C; Chiewsilp P; Siripoonya P
    J Med Assoc Thai; 1988 Aug; 71(8):413-6. PubMed ID: 2978040
    [No Abstract]   [Full Text] [Related]  

  • 11. Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers.
    Poovorawan Y; Sanpavat S; Pongpunlert W; Chumdermpadetsuk S; Sentrakul P; Safary A
    JAMA; 1989 Jun; 261(22):3278-81. PubMed ID: 2523981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of perinatal transmission of hepatitis B virus: prenatal screening of all pregnant women for hepatitis B surface antigen.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1988 Jun; 37(22):341-6, 351. PubMed ID: 2967425
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis B immunization in high risk neonates born from HBsAg and HBeAg positive mothers: comparison of standard and low dose regimens.
    Pongpipat D; Suvatte V; Assateerawatts A
    Asian Pac J Allergy Immunol; 1988 Dec; 6(2):107-10. PubMed ID: 2975491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leads from the MMWR. Prevention of perinatal transmission of hepatitis B virus: prenatal screening of all pregnant women for hepatitis B surface antigen.
    JAMA; 1988 Jul; 260(2):165, 169-70. PubMed ID: 2968468
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunogenicity and harmlessness in the newborn of a vaccine (GenHevac B) containing the antigens S and pre-S2].
    Tron F; Soulié JC; Goudeau A; Devillier P; Saliou P
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):901-5. PubMed ID: 1840243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of hepatitis B surface antigenemia after vaccination.
    Katkov WN; Ault MJ; Dubin SB
    Arch Pathol Lab Med; 1989 Nov; 113(11):1290. PubMed ID: 2530960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal-neonatal transmission of hepatitis B virus. Epidemiology and prevention.
    Zanetti AR
    Ann Ist Super Sanita; 1987; 24(2):277-84. PubMed ID: 2969205
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hepatitis B screening in late pregnancy and results of immunization in newborn infants].
    Sidiropoulos D; Wegmann G; Bütler R; von Muralt G
    Schweiz Med Wochenschr; 1988 Mar; 118(9):309-12. PubMed ID: 2965828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. American Academy of Pediatrics Committee on Infectious Diseases: Prevention of hepatitis B virus infections.
    Brunell PA; Bass JW; Daum RS; Gamble WB; Giebink GS; Hall CB; Peter G; Plotkin SA; Hinman AR; Petricciani JC
    Pediatrics; 1985 Feb; 75(2):362-4. PubMed ID: 3155834
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis B vaccination in children: the Taiwan experience.
    Ni YH; Chen DS
    Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.